In particular, high expression of PD1, CTLA4, TIM3, and TIGIT on CD8+ (memory) T cells is associated with relapse in AML patients following allo-HCT [12,27,29,30,31]. This evidence concerns the gene CD8A and acute myeloid leukemia.